These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 39137607)

  • 1. Development of an artificial intelligence-based algorithm for predicting the severity of myxomatous mitral valve disease from thoracic radiographs by using two grading systems.
    Valente C; Wodzinski M; Guglielmini C; Poser H; Chiavegato D; Zotti A; Venturini R; Banzato T
    Res Vet Sci; 2024 Oct; 178():105377. PubMed ID: 39137607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of an artificial intelligence-based method for the diagnosis of the severity of myxomatous mitral valve disease from canine chest radiographs.
    Valente C; Wodzinski M; Guglielmini C; Poser H; Chiavegato D; Zotti A; Venturini R; Banzato T
    Front Vet Sci; 2023; 10():1227009. PubMed ID: 37808107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of vertebral left atrial size for staging of dogs with myxomatous valve disease.
    Mikawa S; Nagakawa M; Ogi H; Akabane R; Koyama Y; Sakatani A; Ogawa M; Miyakawa H; Shigemoto J; Tokuriki T; Toda N; Miyagawa Y; Takemura N
    J Vet Cardiol; 2020 Aug; 30():92-99. PubMed ID: 32707334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary-vein-to-pulmonary-artery ratio can be utilized to evaluate myxomatous mitral valve disease progression in dogs.
    Kim MS; Kim J; Seo MW; Park C
    Am J Vet Res; 2024 Jul; 85(7):. PubMed ID: 38663446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anatomic regurgitant orifice area obtained using 3D-echocardiography as an indicator of severity of mitral regurgitation in dogs with myxomatous mitral valve disease.
    Müller S; Menciotti G; Borgarelli M
    J Vet Cardiol; 2017 Oct; 19(5):433-440. PubMed ID: 28964709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Mitral INsufficiency Echocardiographic score: A severity classification of myxomatous mitral valve disease in dogs.
    Vezzosi T; Grosso G; Tognetti R; Meucci V; Patata V; Marchesotti F; Domenech O
    J Vet Intern Med; 2021 May; 35(3):1238-1244. PubMed ID: 33951235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left Atrial Strain at Different Stages of Myxomatous Mitral Valve Disease in Dogs.
    Nakamura K; Kawamoto S; Osuga T; Morita T; Sasaki N; Morishita K; Ohta H; Takiguchi M
    J Vet Intern Med; 2017 Mar; 31(2):316-325. PubMed ID: 28145607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of vertebral left atrial size as determined from thoracic radiographs for assessment of left atrial size in dogs with myxomatous mitral valve disease.
    Malcolm EL; Visser LC; Phillips KL; Johnson LR
    J Am Vet Med Assoc; 2018 Oct; 253(8):1038-1045. PubMed ID: 30272515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symmetric dimethylarginine in dogs with myxomatous mitral valve disease at various stages of disease severity.
    Valente C; Guglielmini C; Domenech O; Contiero B; Zini E; Poser H
    PLoS One; 2020; 15(9):e0238440. PubMed ID: 32870923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-dimensional echocardiographic estimates of left atrial function in healthy dogs and dogs with myxomatous mitral valve disease.
    Dickson D; Caivano D; Matos JN; Summerfield N; Rishniw M
    J Vet Cardiol; 2017 Dec; 19(6):469-479. PubMed ID: 29111284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left atrial deformation and phasic function determined by two-dimensional speckle-tracking echocardiography in dogs with myxomatous mitral valve disease.
    Caivano D; Rishniw M; Birettoni F; Patata V; Giorgi ME; Porciello F
    J Vet Cardiol; 2018 Apr; 20(2):102-114. PubMed ID: 29459124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of a mitral regurgitation severity index to predict long-term outcome in dogs with myxomatous mitral valve disease.
    Vereb M; Atkins CE; Adin D; Blondel T; Coffman M; Lee S; Guillot E; Ward JL
    J Vet Intern Med; 2024; 38(1):51-60. PubMed ID: 37909399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective pilot study on the predictive significance of plasma miR-30b-5p through the study of echocardiographic modifications in Cavalier King Charles Spaniels affected by different stages of myxomatous mitral valve disease: The PRIME study.
    Ghilardi S; Lecchi C; Bagardi M; Romito G; Colombo FM; Polli M; Franco C; Brambilla PG
    PLoS One; 2022; 17(12):e0274724. PubMed ID: 36574372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Echocardiographic anatomy of the mitral valve in healthy dogs and dogs with myxomatous mitral valve disease.
    Wesselowski S; Borgarelli M; Menciotti G; Abbott J
    J Vet Cardiol; 2015 Jun; 17(2):97-106. PubMed ID: 26003902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot study: Application of artificial intelligence for detecting left atrial enlargement on canine thoracic radiographs.
    Li S; Wang Z; Visser LC; Wisner ER; Cheng H
    Vet Radiol Ultrasound; 2020 Nov; 61(6):611-618. PubMed ID: 32783354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of focused cardiac ultrasonography training in veterinary students to differentiate stages of subclinical myxomatous mitral valve disease in dogs.
    Huh T; Achilles EJ; Massey LK; Loughran KA; Larouche-Lebel É; Convey V; McKaba VF; Crooks A; Kraus MS; Gelzer AR; Oyama MA
    J Vet Intern Med; 2024; 38(3):1325-1333. PubMed ID: 38532734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitral valve morphology assessed by three-dimensional transthoracic echocardiography in healthy dogs and dogs with myxomatous mitral valve disease.
    Menciotti G; Borgarelli M; Aherne M; Wesselowski S; Häggström J; Ljungvall I; Lahmers SM; Abbott JA
    J Vet Cardiol; 2017 Apr; 19(2):113-123. PubMed ID: 28279678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Longitudinal Outcome Of Canine (K9) myxomatous mitral valve disease (LOOK-Mitral registry): Baseline characteristics.
    Franchini A; Borgarelli M; Abbott JA; Menciotti G; Crosara S; Häggström J; Lahmers S; Rosenthal S; Tyrrell W
    J Vet Cardiol; 2021 Aug; 36():32-47. PubMed ID: 34062479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of electrocardiographic parameters in dogs with different stages of myxomatous mitral valve disease.
    Na Y; Lee D; Yun T; Koo Y; Chae Y; Kim H; Yang MP; Kang BT
    Can J Vet Res; 2021 Oct; 85(4):261-270. PubMed ID: 34602730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Echocardiographic parameters for the assessment of congestive heart failure in dogs with myxomatous mitral valve disease and moderate to severe mitral regurgitation.
    Morgan KRS; Monteith G; Raheb S; Colpitts M; Fonfara S
    Vet J; 2020 Sep; 263():105518. PubMed ID: 32928487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.